Article

Increased concentration of circulating acid glycosaminoglycans in chronic lymphocytic leukaemia and essential thrombocythaemia

Istituto Pluridisciplinare di Fisiologia Umana, University of Messina, Italy.
Clinica Chimica Acta (Impact Factor: 2.82). 01/1998; 269(2):185-99. DOI: 10.1016/S0009-8981(97)00200-3
Source: PubMed

ABSTRACT To verify whether the increase in the number of circulating blood cells that synthesize glycosaminoglycans, B-lymphocytes or platelets, in proliferative disorders, may be associated with changes in the circulation of acid glycosaminoglycans, the serum and plasma concentrations of these polysaccharides have been measured in terms of their sugar components, following isolation and purification by chromatographic methods, in patients with chronic lymphocytic leukaemia or with essential thrombocythaemia and in healthy controls. In the patients, the concentrations of total circulating glycosaminoglycans and of both glucosamine-containing and galactosamine-containing serum glycosaminoglycans were significantly higher than in controls. These concentrations did not significantly correlate with the number of lymphocytes in patients with chronic lymphocytic leukaemia and of platelets in patients with essential thrombocythaemia. Analytical data suggest that excess glycosaminoglycans are mainly composed of chondroitin sulphate molecules and contain heparan sulphate structures.

0 Followers
 · 
57 Views
  • Source
    • "It circulates covalently linked to bikunin [13] [14], or as a main product of tissue catabolism or produced by blood cells, such as lymphocytes, associated with a variety of plasma proteins [21] [22]. It is known that the plasma GAG association with low-density lipoproteins could affect some of their physicochemical properties [23] and that some physiological and pathological conditions could lead to an increase in plasma GAG levels [8] [9] [10] [11] [12]. Moreover, mediators of inflammation such as some cytokines and growth factors are able to modulate the size, the degree, and the pattern of sulfation, as well as the degree of epimerization of the GAG chains [24] [25] [26]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several studies have evidenced variations in plasma glycosaminoglycans content in physiological and pathological conditions. In normal human plasma GAGs are present mainly as undersulfated chondroitin sulfate (CS). The aim of the present study was to evaluate possible correlations between plasma CS level/structure and the presence/typology of carotid atherosclerotic lesion. Plasma CS was purified from 46 control subjects and 47 patients undergoing carotid endarterectomy showing either a soft or a hard plaque. The concentration and structural characteristics of plasma CS were assessed by capillary electrophoresis of constituent unsaturated fluorophore-labeled disaccharides. Results showed that the concentration of total CS isomers was increased by 21.4% (P < 0.01) in plasma of patients, due to a significant increase of undersulfated CS. Consequently, in patients the plasma CS charge density was significantly reduced with respect to that of controls. After sorting for plaque typology, we found that patients with soft plaques and those with hard ones differently contribute to the observed changes. In plasma from patients with soft plaques, the increase in CS content was not associated with modifications of its sulfation pattern. On the contrary, the presence of hard plaques was associated with CS sulfation pattern modifications in presence of quite normal total CS isomers levels. These results suggest that the plasma CS content and structure could be related to the presence and the typology of atherosclerotic plaque and could provide a useful diagnostic tool, as well as information on the molecular mechanisms responsible for plaque instability.
    01/2012; 2012(6):281284. DOI:10.1155/2012/281284
  • Source
    • "Thus, we suggest that the increase in HA production observed in LBR-would be related to abnormal HA degradation due to a decrease in Hyal-2 and Hyal-3 mRNA. Since increased HA levels in serum have been reported in breast, ovarian, endometrial, bladder cancer and also in leukemia and lymphoma (Hiltunen et al. 2002; Hasselbalch et al. 1995; Hautmann et al. 2001; Burchardt et al. 2003; Calabro et al. 1998), we analyzed HA levels in mice injected with different lymphoma cells. It has been reported that serum HA levels are higher in patients with metastasis of breast cancer than in nonmetastatic patients (Delpech et al. 1990). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hyaluronan (HA), a component of the extracellular matrix surrounding tumors, modulates tumor progression and the immune response. Dendritic cells (DC) may tolerize or stimulate immunity against cancer. In this report, we study the association between tumor progression, HA levels and DC activation in a lymphoma model. Mice injected with the cells with highest invasive capacity (LBR-) presented increased HA in serum and lymph nodes, and decreased DC activation in infiltrated lymph nodes and liver. These findings could be related to lack of an effective antitumor immune response and suggest that serum HA levels could have a prognostic value in hematological malignancies.
    Immunobiology 12/2011; 217(9):842-50. DOI:10.1016/j.imbio.2011.12.006 · 3.18 Impact Factor
  • Source
    • "Thus, we suggest that the increase in HA production observed in LBR-would be related to abnormal HA degradation due to a decrease in Hyal-2 and Hyal-3 mRNA. Since increased HA levels in serum have been reported in breast, ovarian, endometrial, bladder cancer and also in leukemia and lymphoma (Hiltunen et al. 2002; Hasselbalch et al. 1995; Hautmann et al. 2001; Burchardt et al. 2003; Calabro et al. 1998), we analyzed HA levels in mice injected with different lymphoma cells. It has been reported that serum HA levels are higher in patients with metastasis of breast cancer than in nonmetastatic patients (Delpech et al. 1990). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Upregulation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway has been described in some tumors related to multidrug resistance (MDR). The aim of this work was to analyze the relationship between PI3K/Akt, MDR and NF-kappaB in murine lymphoma cell lines resistant to vincristine (LBR-V160) and doxorubicin (LBR-D160) as well as in the sensitive line (LBR-). PI3K/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines. Vincristine but not doxorubicin increased p-Akt expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines. Wortmannin and LY294002 inhibited P-glycoprotein (Pgp) function and also increased NF-kappaB activity. We concluded that the PI3K/Akt pathway is involved in MDR in lymphoma cell lines and PI3K/Akt inhibition correlates down-regulation of NF-kappaB activity and inhibition Pgp function.
    Leukemia research 02/2009; 33(2):288-96. DOI:10.1016/j.leukres.2008.06.010 · 2.69 Impact Factor
Show more